A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
Clinical trial NCT01585350 · COMPLETED
Trial details
- NCT number
- NCT01585350
- Sponsor
- Craig L Slingluff, Jr
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-07-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.